Martin Zimmermann

10PUBLICATIONS
155CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 02, 2026
Molecular variants, clonal evolution and clinical relevance in pediatric and adult T-cell lymphoblastic neoplasia.

Sarah Sandmann, Marcel Te Vrugt, Gerrit Randau

|Nov 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009.

Hanna Gottschalk, Anja Möricke, Valentino Conter

|Aug 14, 2024
High Parathyroid Hormone Rather than Low Vitamin D Is Associated with Reduced Event-Free Survival in Childhood Cancer.

Corinna Grasemann, Jakob Höppner, Wolfgang Högler

|Jun 25, 2024
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.

Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori

|Feb 07, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression.

Barbara Meissner, Peter Lang, Peter Bader

|Dec 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.

Valentino Conter, Maria Grazia Valsecchi, Gunnar Cario

Pageof 2

Frequent Collaborators

6 joint publications

Martin Schrappe

4 joint publications

Andishe Attarbaschi

4 joint publications

Sarah Elitzur

4 joint publications

Anke Katharina Bergmann